Drugs Previously Listed on the Index to Drug-Specific Information

• Aprotinin (marketed as Trasylol)
• Becaplermin (marketed as Regranex)
• Dolophine (marketed as Methadone)
• Gadolinium
  • Gadobenate Dimeglumine (marketed as Multihance)
  • Gadodiamide (marketed as Omniscan)
  • Gadopentetate Dimeglumine (marketed as Magnivist)
  • Gadoteridol (marketed as Prohance)
  • Gadoversetamide (marketed as Optimark)
• Hydromorphone (marketed as Pallodone)
• Natalizumab (marketed as Tysabri)
• Nimodipine (marketed as Nimotop)
• Omeprazole (marketed as Prilosec) Esomeprazole (marketed as Nexium)
• Pergolide (marketed as Permax)
• Raptiva (efalizumab)
• Rosiglitazone (marketed as Avandia, Avandamet, and Avandaryl)
• Technetium (marketed as NeutroSpec)